| Deborah D Kelty, RNFA | |
|
2495 Old Vincennes Rd, New Albany, IN 47150-5494 | |
| (502) 499-2197 | |
| Not Available |
| Full Name | Deborah D Kelty |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Registered Nurse First Assistant |
| Location | 2495 Old Vincennes Rd, New Albany, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053506154 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WR0006X | Registered Nurse - Registered Nurse First Assistant | 1048311 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah D Kelty, RNFA 2495 Old Vincennes Road, New Albany, IN 47150-5494 Ph: (502) 499-2197 | Deborah D Kelty, RNFA 2495 Old Vincennes Rd, New Albany, IN 47150-5494 Ph: (502) 499-2197 |
News Archive
As intensive efforts are on to counter the virus, a new study by an international team of researchers reports the unexpected success of a bacterium in modulating the immune response in the airway and protecting the cells against infection with this virus.
While the penetration of picture archiving and communication systems (PACS) in European hospitals is 80 per cent, the modern radiology information system (RIS) that drives PACS has only reached a penetration level of about 41 per cent. Legacy RIS modules ubiquitously dominate the market and many hospitals are reluctant to install a new RIS due to complications associated with training a large group of staff as well as concerns over data migration and security.
President Obama said he would use whatever powers his office holds to address this violence. ... Currently, nearly half of all gun sales in the U.S. are conducted without a background check. Criminals, the mentally ill, minors and domestic abusers are all prohibited from purchasing guns, but they all can do so as easily as attending a gun show or going online.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
The group, led by the Ikerbasque professor Ugo Mayor of the UPV/EHU's Department of Biochemistry and Molecular Biology, has just published in the journal Human Molecular Genetics an explanation of the mechanisms affected by Angelman syndrome.
› Verified 6 days ago
Kenneth Griffin, RN WCC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Silvercrest Dr, New Albany, IN 47150 Phone: 812-542-6720 | |
Margaret Lewis-townsend, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3626 Grant Line Rd Ste 105, New Albany, IN 47150 Phone: 812-944-9284 | |
Denise Conway, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 204 Pearl St Ste 201, New Albany, IN 47150 Phone: 812-944-9284 | |
Lauren O'neal, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3626 Grant Line Rd, New Albany, IN 47150 Phone: 812-948-0549 | |
Jade Simone Mirchandani Popp, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3519 Alexis Dr, New Albany, IN 47150 Phone: 502-758-2512 | |
Robert Whittington, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3626 Grant Line Rd, New Albany, IN 47150 Phone: 812-948-0549 |